# Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease

> **NCT03081884** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 61 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** FACBC PET-CT Imaging

## Key facts

- **NCT ID:** NCT03081884
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2021-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03081884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03081884, "Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03081884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*